Centor Score (Modified/McIsaac) for Strep Pharyngitis
The modified McIsaac score includes age adjustments for improved pediatric and elderly accuracy.
ورودیهای بالینی بیمار
حداقل ۳ — حداکثر ۱۲۰ • واحد: years
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Low Risk-1–1
- Moderate Risk2–3
- High Risk4–5
The Centor Score (Modified/McIsaac) for Strep Pharyngitis calculates rapid bedside triage, risk stratification, and urgent clinical decision-making. Key inputs include tonsillar exudate. Scores guide determining acute hospital admission, emergency department discharge safety, or intensive care transfer. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Estimates likelihood that pharyngitis is streptococcal and suggests management course. Modified version includes age adjustment and provides evidence-based approach to antibiotic prescribing and testing decisions.
Clinical Indication
The Centor Score (Modified/McIsaac) for Strep Pharyngitis is indicated for bedside clinical practice to support Estimates likelihood that pharyngitis is streptococcal and suggests management course. Modified version includes age adjustment and provides evidence-based approach to antibiotic prescribing and testing decisions.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Adult and pediatric patients presenting with acute undifferentiated clinical complaints, trauma, or unstable vital signs. Clinical application is indicated across Emergency triage, acute resuscitation bays, observation units, and emergency trauma centers.
Limitations & Contraindications
Score calculations must never delay immediate life-saving airway stabilization, vascular access, or emergent surgical consult.
Clinical Pearls & Action Plan
Adherence to core ABCDE resuscitation principles and bedside clinical gestalt must take absolute precedence over numerical decision tools. Guideline pearl: Score 2-3: RADT and/or culture recommended (11-35% GAS probability).
Modified Centor Score = Tonsillar exudate (1) + Tender cervical nodes (1) + History of fever (1) + Absence of cough (1) + Age adjustment: 3-14 years (+1), 15-44 years (0), ≥45 years (-1). Total range: -1 to +5 points.
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| tonsillar_exudate | string | Yes | Presence of tonsillar swelling or exudate |
| tender_cervical_nodes | string | Yes | Swollen, tender anterior cervical lymph nodes |
| history_of_fever | string | Yes | History of fever (>38°C or 100.4°F) |
| absence_of_cough | string | Yes | Absence of cough |
| age_years | integer | Yes | Patient age in years (affects scoring: 3-14 years +1, 15-44 years 0, ≥45 years -1)(years) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| -1–1 | Low Risk | Low probability of streptococcal infection |
| 2–3 | Moderate Risk | Moderate probability of streptococcal infection |
| 4–5 | High Risk | High probability of streptococcal infection |
Evidence-Based References (EBM)
- Centor RM, Witherspoon JM, Dalton HP, Brody CE, Link K. The diagnosis of strep throat in adults in the emergency room. Med Decis Making. 1981;1(3):239-46. doi: 10.1177/0272989X8100100304.DOI: 10.1177/0272989X8100100304
- McIsaac WJ, White D, Tannenbaum D, Low DE. A clinical score to reduce unnecessary antibiotic use in patients with sore throat. CMAJ. 1998 Jan 13;158(1):75-83.
- McIsaac WJ, Kellner JD, Aufricht P, Vanjaka A, Low DE. Empirical validation of guidelines for the management of pharyngitis in children and adults. JAMA. 2004 Apr 7;291(13):1587-95. doi: 10.1001/jama.291.13.1587.DOI: 10.1001/jama.291.13.1587
- Shulman ST, Bisno AL, Clegg HW, Gerber MA, Kaplan EL, Lee G, Martin JM, Van Beneden C. Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. Clin Infect Dis. 2012 Nov 15;55(10):e86-102. doi: 10.1093/cid/cis629.DOI: 10.1093/cid/cis629